Concepedia

Li-Hua Gong

LG

Statistics

Publications

5

Citations

296

H-Index

5

Active since

2013

Affiliations

Wenzhou Medical University(Current)

First Affiliated Hospital of Wenzhou Medical University

Jinan University

Sun Yat-sen University

Li-Hua Gong is an author at Wenzhou Medical University specializing in oncology, ovarian cancer, and medicine.

ORCID

Publications per year

2013–2019

5

Publications

5

Piperlongumine Induces Apoptosis and Synergizes with Cisplatin or Paclitaxel in Human Ovarian Cancer Cells

Li-Hua Gong, Xiuxiu Chen, Huan Wang et al. · Oxidative Medicine and Cellular Longevity · 2014 · 88 citations · Full text

, , +17

Sequential combination therapy of ovarian cancer with cisplatin and γ-secretase inhibitor MK-0752

Xiuxiu Chen, Li-Hua Gong, Rongying Ou et al. · Gynecologic Oncology · 2015 · 70 citations

, , +15

Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer

Xiuxiu Chen, Fengfeng Xie, Xiu-Jie Zhu et al. · Oncotarget · 2015 · 61 citations · Full text

, , +17

Survivin Status Affects Prognosis and Chemosensitivity in Epithelial Ovarian Cancer

Lifeng Chen, Li‐Zhi Liang, Xiaojian Yan et al. · International Journal of Gynecological Cancer · 2013 · 60 citations

, , +13

Survivin Promotes Piperlongumine Resistance in Ovarian Cancer

Xing-Wei Nan, Li-Hua Gong, Xu Chen et al. · Frontiers in Oncology · 2019 · 17 citations · Full text

, , +17

1–5 of 5